Best Specialty Pharma Stocks Picked by UBS
UBS Investment Research published a report entitled “UBS Pharma- Large Cap and Specialty” on January 11, 2012. The report isn’t publicy available but we will summarize its main points. In their...
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1.) | Expo Capital Management Paul Sinclair |
1,250,000 | $18,913 |  |
4.64% |
| 2.) | Hound Partners Jonathan Auerbach |
2,077,802 | $31,437 | +22% |
3.82% |
| 3.) | Orbimed Advisors Samuel Isaly |
4,246,100 | $64,243 | +1% |
2.1% |
| 4.) | Ascend Capital Malcolm Fairbairn |
514,919 | $7,792 | -63% |
1.04% |
| 5.) | Brigade Capital Don Morgan |
1,050,000 | $15,887 | +600% |
0.87% |
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.9992 | 558 | Officer | 193345 | 2012-03-01 | Filing | |
| $16.9992 | 386 | Officer | 96617 | 2012-03-01 | Filing | |
| $16.9992 | 973 | Officer | 68640 | 2012-03-01 | Filing | |
| $16.9992 | 710 | Officer | 200878 | 2012-03-01 | Filing | |
| $16.9992 | 710 | Officer | 237176 | 2012-03-01 | Filing |
